Global Trend in Research and Development of CDK4/6 Inhibitors for Clinical Cancer Therapy: A Bibliometric Analysis

Background: Cyclin-dependent kinase (CDK) 4/6 inhibitors are frequently used anti-cancer agents in hormone receptor-positive breast cancers. This study assessed the course of research and development (R&D) for CDK4/6 inhibitors in terms of publications over the past two decades. Methods: The Web...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Hongna, Jiang, Wei, Zhao, Jianli, Dinglin, Xiaoxiao, Li, Yudong, Li, Shunying, Wang, Ying, Yao, Herui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120189/
https://www.ncbi.nlm.nih.gov/pubmed/33995631
http://dx.doi.org/10.7150/jca.51609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120189/
https://www.ncbi.nlm.nih.gov/pubmed/33995631
http://dx.doi.org/10.7150/jca.51609

Ejemplares similares